Science of composite tissue allotransplantation

Bruce Swearingen, Kadiyala Ravindra, Hong Xu, Shengli Wu, Warren C Breidenbach, Suzanne T. Ildstad

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The science of composite tissue allotransplantation (CTA) is rooted in progressive thinking by surgeons, fueled by innovative solutions, and aided by understanding the immunology of tolerance and rejection. These three factors have allowed CTA to progress from science fiction to science fact. Research using preclinical animal models has allowed an understanding of the antigenicity of complex tissue transplants and mechanisms to promote graft acceptance. As a result, translation to the clinic has shown that CTA is a viable treatment option well on the way of becoming a standard of care for those who have lost extremities and suffered large tissue defects. The field of CTA has been progressing exponentially over the past decade. Transplantation of hands, larynx, vascularized knee, trachea, face, and abdominal wall has been performed. Several important observations have emerged from translation to the clinic. Although it was predicted that rejection would pose a major limitation, this has not proven true. In fact, steroid-sparing protocols for immunosuppression that have been successfully used in renal transplantation are sufficient to prevent rejection of limbs. Although skin is highly antigenic when transplanted alone in animal models, when part of a CTA, it has not proven to be. Chronic rejection has not been conclusively demonstrated in hand transplant recipients and is difficult to induce in rodent models of CTA. This review focuses on the science of CTA, provides a snapshot of where we are in the clinic, and discusses prospects for the future to make the procedures even more widely available.

Original languageEnglish (US)
Pages (from-to)627-635
Number of pages9
JournalTransplantation
Volume86
Issue number5
DOIs
StatePublished - Sep 15 2008
Externally publishedYes

Fingerprint

Vascularized Composite Allotransplantation
Hand Transplantation
Extremities
Animal Models
Transplants
Abdominal Wall
Standard of Care
Larynx
Allergy and Immunology
Trachea
Kidney Transplantation
Immunosuppression
Rodentia
Knee
Hand
Steroids
Skin

Keywords

  • Allotransplantation
  • Composite tissue
  • Hand
  • Laryngeal transplant

ASJC Scopus subject areas

  • Transplantation

Cite this

Swearingen, B., Ravindra, K., Xu, H., Wu, S., Breidenbach, W. C., & Ildstad, S. T. (2008). Science of composite tissue allotransplantation. Transplantation, 86(5), 627-635. https://doi.org/10.1097/TP.0b013e318184ca6a

Science of composite tissue allotransplantation. / Swearingen, Bruce; Ravindra, Kadiyala; Xu, Hong; Wu, Shengli; Breidenbach, Warren C; Ildstad, Suzanne T.

In: Transplantation, Vol. 86, No. 5, 15.09.2008, p. 627-635.

Research output: Contribution to journalArticle

Swearingen, B, Ravindra, K, Xu, H, Wu, S, Breidenbach, WC & Ildstad, ST 2008, 'Science of composite tissue allotransplantation', Transplantation, vol. 86, no. 5, pp. 627-635. https://doi.org/10.1097/TP.0b013e318184ca6a
Swearingen B, Ravindra K, Xu H, Wu S, Breidenbach WC, Ildstad ST. Science of composite tissue allotransplantation. Transplantation. 2008 Sep 15;86(5):627-635. https://doi.org/10.1097/TP.0b013e318184ca6a
Swearingen, Bruce ; Ravindra, Kadiyala ; Xu, Hong ; Wu, Shengli ; Breidenbach, Warren C ; Ildstad, Suzanne T. / Science of composite tissue allotransplantation. In: Transplantation. 2008 ; Vol. 86, No. 5. pp. 627-635.
@article{1aa06512f57b4604b4b97c248291f155,
title = "Science of composite tissue allotransplantation",
abstract = "The science of composite tissue allotransplantation (CTA) is rooted in progressive thinking by surgeons, fueled by innovative solutions, and aided by understanding the immunology of tolerance and rejection. These three factors have allowed CTA to progress from science fiction to science fact. Research using preclinical animal models has allowed an understanding of the antigenicity of complex tissue transplants and mechanisms to promote graft acceptance. As a result, translation to the clinic has shown that CTA is a viable treatment option well on the way of becoming a standard of care for those who have lost extremities and suffered large tissue defects. The field of CTA has been progressing exponentially over the past decade. Transplantation of hands, larynx, vascularized knee, trachea, face, and abdominal wall has been performed. Several important observations have emerged from translation to the clinic. Although it was predicted that rejection would pose a major limitation, this has not proven true. In fact, steroid-sparing protocols for immunosuppression that have been successfully used in renal transplantation are sufficient to prevent rejection of limbs. Although skin is highly antigenic when transplanted alone in animal models, when part of a CTA, it has not proven to be. Chronic rejection has not been conclusively demonstrated in hand transplant recipients and is difficult to induce in rodent models of CTA. This review focuses on the science of CTA, provides a snapshot of where we are in the clinic, and discusses prospects for the future to make the procedures even more widely available.",
keywords = "Allotransplantation, Composite tissue, Hand, Laryngeal transplant",
author = "Bruce Swearingen and Kadiyala Ravindra and Hong Xu and Shengli Wu and Breidenbach, {Warren C} and Ildstad, {Suzanne T.}",
year = "2008",
month = "9",
day = "15",
doi = "10.1097/TP.0b013e318184ca6a",
language = "English (US)",
volume = "86",
pages = "627--635",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Science of composite tissue allotransplantation

AU - Swearingen, Bruce

AU - Ravindra, Kadiyala

AU - Xu, Hong

AU - Wu, Shengli

AU - Breidenbach, Warren C

AU - Ildstad, Suzanne T.

PY - 2008/9/15

Y1 - 2008/9/15

N2 - The science of composite tissue allotransplantation (CTA) is rooted in progressive thinking by surgeons, fueled by innovative solutions, and aided by understanding the immunology of tolerance and rejection. These three factors have allowed CTA to progress from science fiction to science fact. Research using preclinical animal models has allowed an understanding of the antigenicity of complex tissue transplants and mechanisms to promote graft acceptance. As a result, translation to the clinic has shown that CTA is a viable treatment option well on the way of becoming a standard of care for those who have lost extremities and suffered large tissue defects. The field of CTA has been progressing exponentially over the past decade. Transplantation of hands, larynx, vascularized knee, trachea, face, and abdominal wall has been performed. Several important observations have emerged from translation to the clinic. Although it was predicted that rejection would pose a major limitation, this has not proven true. In fact, steroid-sparing protocols for immunosuppression that have been successfully used in renal transplantation are sufficient to prevent rejection of limbs. Although skin is highly antigenic when transplanted alone in animal models, when part of a CTA, it has not proven to be. Chronic rejection has not been conclusively demonstrated in hand transplant recipients and is difficult to induce in rodent models of CTA. This review focuses on the science of CTA, provides a snapshot of where we are in the clinic, and discusses prospects for the future to make the procedures even more widely available.

AB - The science of composite tissue allotransplantation (CTA) is rooted in progressive thinking by surgeons, fueled by innovative solutions, and aided by understanding the immunology of tolerance and rejection. These three factors have allowed CTA to progress from science fiction to science fact. Research using preclinical animal models has allowed an understanding of the antigenicity of complex tissue transplants and mechanisms to promote graft acceptance. As a result, translation to the clinic has shown that CTA is a viable treatment option well on the way of becoming a standard of care for those who have lost extremities and suffered large tissue defects. The field of CTA has been progressing exponentially over the past decade. Transplantation of hands, larynx, vascularized knee, trachea, face, and abdominal wall has been performed. Several important observations have emerged from translation to the clinic. Although it was predicted that rejection would pose a major limitation, this has not proven true. In fact, steroid-sparing protocols for immunosuppression that have been successfully used in renal transplantation are sufficient to prevent rejection of limbs. Although skin is highly antigenic when transplanted alone in animal models, when part of a CTA, it has not proven to be. Chronic rejection has not been conclusively demonstrated in hand transplant recipients and is difficult to induce in rodent models of CTA. This review focuses on the science of CTA, provides a snapshot of where we are in the clinic, and discusses prospects for the future to make the procedures even more widely available.

KW - Allotransplantation

KW - Composite tissue

KW - Hand

KW - Laryngeal transplant

UR - http://www.scopus.com/inward/record.url?scp=53449094578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449094578&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e318184ca6a

DO - 10.1097/TP.0b013e318184ca6a

M3 - Article

C2 - 18791440

AN - SCOPUS:53449094578

VL - 86

SP - 627

EP - 635

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -